Steve Morgan: National Pharmacare

“A Canadian (Drug) sticker price that comes down -at all- is a big threat south of the border (to the US’s) automobile dealership sales technique for drugs (&) the world’s most inflated, most ridiculous, if I can say, list prices of medicines.”

Steve Morgan believes National Pharmacare would serve Canadians better than the current system. Today Canada’s drug coverage is fragmented into more than a hundred federal, provincial or territorial drug plans–and literally thousands of private plans. He contends National Pharmacare could save billions in duplicated administrative costs and reduce medical error, all while creating innovation opportunities and bringing equality in care to all Canadians.

Show Notes:

•Steve Morgan (Twitter)

•Steve Morgan, UBC School of Population & Public Health

•Steve Morgan, Marc-Andre Gagnon addressing MP’s in Health Committee on March 19th, 2012

•(Paul Grootendorst, Livio Di Matteo) The Effect of Pharmaceutical Patent Term Length on Research and Development and Drug Expenditures in Canada

Patented Medicines Pricing Review Board 2016 Annual Report

•(Fraser Institute) The Unintended Consequences of National Pharmacare Programs

•(Broadbent Institute)Charting the Path to National Pharmacare in Canada

•(Steve Morgan, Michael Law, et al) Estimated cost of universal public coverage of prescription drugs in Canada

•(Michael R Law, et al) The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey

•(Marc-Andre Gagnon) A roadmap to a Rational Pharmacare Policy in Canada

•(Joel Lexchin) Six Reasons We Need Pharmacare

•(Kelly Crowe) Canada Has found the key to lowering drug prices, but it won’t be used any time soon